Claire Mazumdar, Chief Executive Officer at Bicara Therapeutics Inc. (BCAX), sold 82,326 shares at $18.86 ($1.6M) on 2025-11-24, disclosed to the SEC on 2025-11-25.
Scheduled sale ($1.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.86 | 41,163 | $776K | 50.0% |
| 2 | $18.86 | 41,163 | $776K | 50.0% |
| Total | $18.86 avg | 82,326 | $1.6M | 100% |
| Filing → |
| BCAX | SELL | 2026-05-20 | $301K | — | Filing → |
| BCAX | SELL | 2026-04-20 | $354K | — | Filing → |
| BCAX | SELL | 2026-03-20 | $565K | — | Filing → |